(Q31171036)

English

Expression of gastrin releasing Peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Expression of gastrin releasing Peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

3

object named as

Schally AV

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

author name string

Heuser M

1

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Schlott T

2

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Kahler E

4

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Schliephake R

5

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Laabs SO

6

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Hemmerlein B

7

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

173

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

2154-2159

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

Characterization of gastrin-releasing peptide receptors aberrantly expressed by non-antral gastric adenocarcinomas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

Guidelines on renal cell cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

Inhibition of the growth of Caki-I human renal adenocarcinoma in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

Impact of gastrin-releasing peptide on intestinal microcirculation after ischemia-reperfusion in rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

Gastrin-releasing peptide is a growth factor for human neuroblastomas.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

Dynamic assessment of angiogenesis in renal cell carcinoma spheroids by intravital microscopy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

The action of bombesin on the kidney of the anaesthetized dog.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.JU.0000158135.26893.BC

Identifiers

10.1097/01.JU.0000158135.26893.BC

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31171036&oldid=1751266835"